Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 208,904 | 250,135 | 202,920 | 229,396 | 176,549 |
| Cost of Goods | 34,904 | 38,063 | 30,998 | 38,321 | 29,920 |
| Gross Profit | 174,000 | 212,072 | 171,922 | 191,075 | 146,629 |
| Operating Expenses | 256,777 | 276,423 | 238,780 | 250,152 | 136,346 |
| Operating Income | -81,873 | -64,288 | -65,860 | -58,756 | 11,203 |
| Interest Expense | 9,447 | 10,002 | 9,462 | 9,197 | 9,118 |
| Other Income | 877 | -8,253 | 619 | 2,216 | 1,136 |
| Pre-tax Income | -90,443 | -82,543 | -74,703 | -65,737 | 3,221 |
| Income Tax | 483 | -554 | -7,202 | 4,060 | -4,224 |
| Net Income Continuous | -90,926 | -81,989 | -67,501 | -69,797 | 7,445 |
| Net Income | $-90,926 | $-81,989 | $-67,501 | $-69,797 | $7,445 |
| EPS Basic Total Ops | -0.57 | -0.51 | -0.43 | -0.48 | 0.05 |
| EPS Basic Continuous Ops | -0.57 | -0.51 | -0.43 | -0.47 | 0.05 |
| EPS Diluted Total Ops | -0.60 | -0.51 | -0.43 | -0.47 | 0.05 |
| EPS Diluted Continuous Ops | -0.56 | -0.51 | -0.43 | -0.47 | 0.05 |
| EBITDA(a) | $-69,160 | $-52,318 | $-54,626 | $-51,327 | $27,435 |